Oliclinomel N5-800e

A mixture of essential amino acids (valine, alanine, arginine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine), the active ingredient in Oliclinomel N5-800e, is an amino acid solution presented as a solution for injection for intravenous use. It provides essential amino acids for patients requiring parenteral nutrition and those unable to receive enteral feeding.

GNH USA supplies Oliclinomel N5-800e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oliclinomel N5-800e is used in the context of parenteral nutrition and amino acid supplementation for patients who cannot take food orally. - Parenteral nutrition: supports protein synthesis and metabolic needs when enteral feeding is not possible. - Amino acid supplementation: restores essential amino acid levels in patients with prolonged fasting or malnutrition. - Critical illness: helps maintain nitrogen balance and muscle mass in critically ill patients.

Adverse reactions may occur with intravenous amino acid solutions. Monitoring and prompt management are recommended.

Common Side Effects: - Mild hyperglycemia: transient elevation of blood glucose levels. - Electrolyte disturbances: temporary shifts in potassium, sodium, or calcium. - Infusion site erythema: redness or irritation at the catheter site. - Nausea: mild gastrointestinal discomfort. - Headache: transient headache during or after infusion. - Taste alteration: temporary metallic taste.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate intervention. - Severe hyperosmolarity: excessive osmotic load leading to neurologic symptoms. - Metabolic acidosis: significant drop in blood pH. - Hepatic dysfunction: abnormal liver enzyme elevations. - Renal impairment: worsening kidney function in susceptible patients. - Severe electrolyte imbalance: life‑threatening potassium or calcium shifts.

When using Oliclinomel N5-800e, clinicians should observe several safety measures. - Renal function assessment: evaluate baseline kidney status before infusion. - Blood glucose monitoring: check glucose levels regularly, especially in diabetic patients. - Electrolyte monitoring: track serum electrolytes during therapy. - Aseptic technique: ensure sterile handling of the infusion set. - Dose adjustment in hepatic impairment: modify infusion rates if liver function is compromised. - Hypersensitivity screening: avoid use in patients with known allergy to any amino acid component. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Amino acid infusions can interact with other therapies; awareness helps prevent complications.

Major Interactions (Avoid): - High‑dose glucose solutions: may exacerbate hyperglycemia. - Nephrotoxic drugs (e.g., aminoglycosides): increase renal load and risk of injury. - Large electrolyte supplements: can cause dangerous electrolyte overload.

Moderate Interactions (Monitor Closely): - Loop diuretics: may amplify electrolyte shifts. - Corticosteroids: can affect protein catabolism and nitrogen balance. - Insulin therapy: requires tighter glucose monitoring. - Other parenteral nutrition components: adjust concentrations to avoid incompatibility. - Anticoagulants: monitor clotting parameters as amino acids may influence platelet function.